Skip to main content

Table 2 Demographic and clinical characteristics of all patients included in the study

From: Safety and efficacy of dehydrated ethanol soaking of the operative field in the treatment of spontaneous hepatocellular carcinoma rupture

  DAW group DW group P value
  N = 21 N = 24  
Age, years 48.6 (22-81) 46.8 (22-71) 0.688
Male to female 17:4 20:4 1.000
HBV positivitya 16 (76.2%) 21 (87.5%) 0.549
Tumor location    0.607
 Left lobe 5 (23.8%) 6 (25%)  
 Right lobe 12 (57.1% 15 (62.5%)  
 Both left and right lobe 4 (19.1%) 3 (12.5%)  
Child-Pugh classificationa    0.551
 A 20 (95.2%) 22 (91.7%)  
 B 1 (4.8%) 2 (8.3%)  
 C 0 0  
Pre-operation TACEa 0 3 (12.5%) 0.236
AST, IU/L 70.7 (29–160) 78.6 (22–347) 0.795
ALT, IU/L 47.8 (16–162) 59.3 (26–152) 0.507
AFP, IU/mL 45,705.0 (1.14–225,046) 32,254.8 (2.41–129,869) 0.662
Tumor size, cm 9.3 (4–20) 8.3 (3–21.5) 0.713
Tumor numbera    0.127
 Single 16 (76.2%) 21 (87.5%)  
 Multiple 5 (23.8%) 3 (12.5%)  
Vascular invasiona 12 (57.1%) 15 (62.5%) 0.714
Organ invasiona 7 (33.3%) 5 (20.8%) 0.344
Liver cirrhosisa    0.705
 Yes 3 (14.3%) 5 (20.8%)  
 No 18 (85.7%) 19 (79.2%)  
  1. Values in parentheses are medians with range unless indicated otherwise
  2. HBV hepatitis B virus, TACE transhepatic arterial chemotherapy and embolization, AST aspartate aminotransferase, ALT alanine transaminase, AFP alpha fetal protein
  3. aValues are number with percentages